|Articles|May 6, 2021
Quantification of Vector Genomic DNA and Residual DNA in Gene Therapy Vectors Using ddPCR
Author(s)Thermo Fisher Scientific
To bring lifesaving cell and gene therapies to the market, an efficient and scalable manufacturing strategy is needed. Find out more in this whitepaper.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
2
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
3
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
4
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
5